Literature DB >> 8622610

Mechanisms of cachexia induced by T-cell leukemia in the rat.

S Roe1, A L Cooper, I D Morris, N J Rothwell.   

Abstract

Body wasting (cachexia) is a common feature of cancer and a major cause of morbidity and mortality. The mechanisms underlying cachexia are largely unknown, and studies in experimental animals have focused mainly on solid tumors. Therefore, the objective of the present study was to quantify and investigate cachexia in experimentally induced T-cell leukemia in the rat. Induction of leukemia by serial passage (injection of cervical lymph node suspension) resulted in a rapid increase in white blood cell (WBC count, hypertrophy of the spleen (by day 11), and severe morbidity within 17 to 18 days. Body weight gain and food intake declined steadily in leukemic animals from day 12, although weight loss was significantly greater in pair-fed, nonleukemic animals. However, leukemic rats had a lower body fat content and higher water content than pair-fed animals on day 18, so the measurement of body weight significantly underestimated the severity of cachexia. Resting oxygen consumption (VO2), measured during the light phase, declined in pair-fed animals from day 13, but was elevated in leukemic rats on days 12 to 18 by 25% (P < .05, one-way ANOVA) compared with pair-fed rats and by 7% (P < .05, one-way ANOVA) relative to free-feeding controls. Hypermetabolism was associated with an increase in brown adipose tissue (BAT) activity (74% and 89%, respectively, P < .05, one-way ANOVA) in leukemic rats compared with control and pair-fed groups. Effects of leukemia on VO2 and BAT were prevented by administration of the adrenergic antagonist, propranolol. These results indicate that T-cell leukemia in the rat results in rapid and severe cachexia, which is largely due to marked hypophagia, but is also accompanied by inappropriately high rates of energy expenditure that are mediated by sympathetic activation of BAT thermogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622610     DOI: 10.1016/s0026-0495(96)90037-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

1.  Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia.

Authors:  Serkan Kir; James P White; Sandra Kleiner; Lawrence Kazak; Paul Cohen; Vickie E Baracos; Bruce M Spiegelman
Journal:  Nature       Date:  2014-07-13       Impact factor: 49.962

Review 2.  Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia.

Authors:  Bahar Zehra Camurdanoglu Weber; Dilsad H Arabaci; Serkan Kir
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

3.  PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer.

Authors:  Serkan Kir; Hirotaka Komaba; Ana P Garcia; Konstantinos P Economopoulos; Wei Liu; Beate Lanske; Richard A Hodin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2015-12-06       Impact factor: 27.287

4.  Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy.

Authors:  Alejandro Schcolnik-Cabrera; Alma Chavez-Blanco; Guadalupe Dominguez-Gomez; Mandy Juarez; Ariana Vargas-Castillo; Rafael Isaac Ponce-Toledo; Donna Lai; Sheng Hua; Armando R Tovar; Nimbe Torres; Delia Perez-Montiel; Jose Diaz-Chavez; Alfonso Duenas-Gonzalez
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

Review 5.  A role of active brown adipose tissue in cancer cachexia?

Authors:  Emiel Beijer; Janna Schoenmakers; Guy Vijgen; Fons Kessels; Anne-Marie Dingemans; Patrick Schrauwen; Miel Wouters; Wouter van Marken Lichtenbelt; Jaap Teule; Boudewijn Brans
Journal:  Oncol Rev       Date:  2012-06-12

6.  Cachexia: a problem of energetic inefficiency.

Authors:  Josep M Argilés; Cibely Cristine Fontes-Oliveira; Miriam Toledo; Francisco J López-Soriano; Sílvia Busquets
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-08-15       Impact factor: 12.910

7.  Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives.

Authors:  Hannes Zwickl; Elisabeth Zwickl-Traxler; Martin Pecherstorfer
Journal:  Front Oncol       Date:  2019-12-20       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.